AFMD - 3 Catalysts in 2Q 2024Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. The company is also developing single and combination therapies to treat cancers and other life-threatening diseases. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe and Germany.
Investment Insight: Key Catalysts & Strategy for Q2 2024
Disclaimer: This is for informational purposes only and not to be taken as financial advice.
As we navigate through the second quarter of 2024, certain investment opportunities present themselves as slower, yet potentially rewarding plays. Based on current analyst ratings and a positive outlook towards these options, here are some critical points and strategies investors might consider:
1. Anticipated Catalysts: The upcoming quarter is expected to unveil several catalysts that could influence market dynamics. While specific details of these catalysts were not provided, their potential impact suggests the necessity for strategic positioning and monitoring.
2. Market Sentiment: The overall bullish sentiment in the market plays a crucial role in the success of our identified investment strategy. However, it's important to remain cautious. Any significant market correction could undermine the effectiveness of this approach. Investors should stay updated on broader market trends to adjust their strategies accordingly.
3. Key Price Levels to Watch:
Breakout Point: The $6.0 price level is pivotal. A breakthrough above this level may signal a more substantial upward movement. However, anticipate possible resistance at this juncture, potentially leading to a minor retracement.
Subsequent Targets: Investors should also monitor the $6.5 and $7.0 levels. Overcoming these thresholds could further confirm the bullish trend, presenting opportunities to secure partial profits and reinvest or hold according to individual risk appetites.
Support Level: Setting a stop loss (SL) just below the $5.0 mark can help mitigate potential losses if the market moves against our expectations.
Profit Target (TP): The approximate target for taking profits stands at $9.0, contingent upon successfully navigating the aforementioned price levels and maintaining a favorable market sentiment.
4. Chart Analysis: For a comprehensive understanding, it's recommended to consult detailed chart analyses. Charts can provide valuable insights into historical price actions, trends, and potential resistance or support levels.
5. Trading Strategy: Trading in such a volatile environment requires careful consideration and vigilance. Investors should:
Stay informed about overall market conditions and sentiment.
Be prepared for potential pullbacks, especially around critical price levels.
Consider taking partial profits to secure gains and manage risks effectively.
Final Note: While the outlined strategy and insights aim to guide investors through Q2 2024, it's essential to conduct personal research and consider individual financial situations before making investment decisions. Market conditions can change rapidly, and it's important to adapt strategies as needed.
Trade cautiously and always consider the broader market context in your investment decisions.
AFMD trade ideas
$AFMD Pump its been a while
reasons for pump:
after a long downtrend, price has formed a base above a 3 day demand block.
price has had a bullish reaction off a triple tap of support (triple bottom).
base looks to be accumulation with a bullish divergence on the daily RSI.
unusually high v
EMA's are beginning to turn upwards after much consolidation.
looking to play the expansion phase of this consolidation, with an entry at the retest upon breakout.
tp 1 = $8.47 (i expect higher)
tp 2 = $11.00
stop below 12 hr breaker
glhf
🟢 NEW POSITION $AFMD Target 9.62 for 28.27%$AFMD Target 9.62 for 28.27%
Or double position at 5.38
This one filled in pre-market… That's a pretty decent looking chart...
—
On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average.
I start every position with 1% of my account and build from there as needed and as possible.
I am not your financial advisor. Watch my setups first before you jump in… My trade set ups work very well and they are for my personal reference and if you decide to trade them you do so at your own risk. I will gladly answer questions to the best of my knowledge but ultimately the risk is on you. I will update targets as needed.
GL and happy trading.
I finally added my YouTube Training Video to my profile tagline since I’m not allowed to on here. It’s a quick 15 minute training video on how to set up your chart and how to spot opportunities. So check here first but If you have questions just message me.
$AFMD can rise in the next daysContextual immersion trading strategy idea.
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Europe, and Germany.
The demand for shares of the company looks higher than the supply.
This and other conditions can cause a rise in the share price in the next days.
So I opened a long position from $7,54;
stop-loss — $6,70.
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
AFMD: Bullish Pennant (46%)Bullish Pennant (46%)
Pros:
Volume during post formation
Descending volume during triangle formation
PPS above 50MA and 200MA
RS above 0 and ascending
ATR Ascending
R/R ratio above 6
250RSI above 50 and ascending
200MA ascending
Target:
PT = 12.10$
Help how ever you can to keep this alive.
Thank you to those who have donated Coins!
Always do your own due dilligence. This is not financial advice
Stay Humble, have fun, make money!
Education:
www.dailyfx.com
US Stock In Play: $AFMD (Affimed NV)$AFMD subdued an early session sell off, recovering +7.78% intraday closing above the previous day's closing at $6.79. During the month, AFMD have successfully exhibited a major MA golden cross (50D vs 100D) before the breakout to its 52 weeks high, following with a +21% runaway gap closing on Monday's market session.
At the current juncture, $AFMD will be challenging its 2-year high of $7.35, the immediate resistance level we will be watching.
AFMD is gearing up to move higher over the coming weeks.While looking at the support and resistance lines, it becomes clear the support lines are more consolidated while the resistance lines have a larger spread. This leave an interpretation that there's much more room for AFMD to grow rather than to fall. Additionally, beyond the technicals the EPS for the previous quarter left investors shocked because of the significant increase in surprise. Also, the news for AFMD has been positive, and they have attended recent conferences hinting at game changing news over the horizon.
Affimed is gearing up.While analyzing the current support and resistance lines, I believe Affimed is ready to soar higher over the coming weeks. It's also worth noting that the recent EPS for the last quarter was significantly higher than the expected, leaving a lasting and big surprise for investors. Meanwhile, Affimed has presented at several conferences and proved that big news is in the making.